Repro Med Systems, Inc. (KRMD): Price and Financial Metrics


Repro Med Systems, Inc. (KRMD): $3.91

-0.03 (-0.76%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

KRMD Stock Summary

  • KRMD's price/sales ratio is 6.6; that's higher than the P/S ratio of 82.47% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.25 for KORU MEDICAL SYSTEMS INC; that's greater than it is for merely 15.67% of US stocks.
  • With a year-over-year growth in debt of 528.52%, KORU MEDICAL SYSTEMS INC's debt growth rate surpasses 96.57% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to KORU MEDICAL SYSTEMS INC are KTOS, VCYT, EKSO, FTFT, and UDMY.
  • KRMD's SEC filings can be seen here. And to visit KORU MEDICAL SYSTEMS INC's official web site, go to www.korumedical.com.

KRMD Valuation Summary

  • KRMD's price/sales ratio is 6.5; this is 217.07% higher than that of the median Healthcare stock.
  • KRMD's price/sales ratio has moved up 6.2 over the prior 243 months.

Below are key valuation metrics over time for KRMD.

Stock Date P/S P/B P/E EV/EBIT
KRMD 2023-01-20 6.5 5.4 -22.7 -16.9
KRMD 2023-01-19 6.5 5.4 -22.8 -17.0
KRMD 2023-01-18 6.4 5.4 -22.5 -16.7
KRMD 2023-01-17 6.5 5.4 -22.8 -17.0
KRMD 2023-01-13 6.0 5.0 -21.0 -15.6
KRMD 2023-01-12 6.7 5.6 -23.5 -17.6

KRMD Growth Metrics

    Its 5 year net cashflow from operations growth rate is now at 558.09%.
  • The 4 year cash and equivalents growth rate now stands at 107.73%.
  • Its 4 year net cashflow from operations growth rate is now at 558.09%.
KRMD's revenue has moved up $3,879,241 over the prior 33 months.

The table below shows KRMD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 27.04186 -7.458145 -7.752773
2022-06-30 25.32201 -6.168674 -7.620991
2022-03-31 24.30355 -3.465929 -5.824199
2021-12-31 23.49018 -4.31951 -4.562823
2021-09-30 21.05689 -5.314138 -4.329093
2021-06-30 21.09666 -6.227022 -2.98614

KRMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • KRMD has a Quality Grade of D, ranking ahead of 19.43% of graded US stocks.
  • KRMD's asset turnover comes in at 0.501 -- ranking 94th of 186 Medical Equipment stocks.
  • CSII, NVRO, and XENT are the stocks whose asset turnover ratios are most correlated with KRMD.

The table below shows KRMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.501 0.601 -0.483
2021-03-31 0.531 0.618 -0.535
2020-12-31 0.646 0.618 -0.188
2020-09-30 0.852 0.630 -0.036
2020-06-30 1.170 0.634 0.047
2020-03-31 1.753 0.636 0.245

KRMD Price Target

For more insight on analysts targets of KRMD, see our KRMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $5.17 Average Broker Recommendation 1.83 (Hold)

KRMD Stock Price Chart Interactive Chart >

Price chart for KRMD

KRMD Price/Volume Stats

Current price $3.91 52-week high $4.18
Prev. close $3.94 52-week low $1.82
Day low $3.72 Volume 80,900
Day high $3.99 Avg. volume 50,528
50-day MA $3.40 Dividend yield N/A
200-day MA $2.66 Market Cap 177.04M

Repro Med Systems, Inc. (KRMD) Company Bio


Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.


KRMD Latest News Stream


Event/Time News Detail
Loading, please wait...

KRMD Latest Social Stream


Loading social stream, please wait...

View Full KRMD Social Stream

Latest KRMD News From Around the Web

Below are the latest news stories about KORU MEDICAL SYSTEMS INC that investors may wish to consider to help them evaluate KRMD as an investment opportunity.

KORU Medical Systems to Participate in the Piper Sandler 34th Annual Healthcare Conference

MAHWAH, N.J., November 21, 2022--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will participate in the Piper Sandler 34th Annual Healthcare Conference on December 1st, 2022.

Yahoo | November 21, 2022

KORU Medical Systems to Participate in Upcoming Investor Conferences

MAHWAH, N.J., November 10, 2022--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will participate in two upcoming investor conferences.

Yahoo | November 10, 2022

KORU Medical Systems Announces 2022 Third Quarter Financial Results

MAHWAH, N.J., November 09, 2022--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today reported financial results for the third quarter ended September 30, 2022.

Yahoo | November 9, 2022

KORU Medical Systems Announces Novel Therapy Collaboration for Three Indications with Kira Pharmaceuticals

MAHWAH, N.J., November 08, 2022--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of innovative and easy-to-use subcutaneous infusion solutions, today announced the progression of its agreement with Kira Pharmaceuticals, including expansion into three important additional indications.

Yahoo | November 8, 2022

KORU Medical Systems to Report Third Quarter 2022 Financial Results on November 9, 2022

MAHWAH, N.J., October 26, 2022--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced that the Company will report third quarter 2022 financial results on Wednesday, November 9, 2022. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Yahoo | October 26, 2022

Read More 'KRMD' Stories Here

KRMD Price Returns

1-mo 15.00%
3-mo 63.60%
6-mo 53.94%
1-year 41.67%
3-year -35.90%
5-year 279.61%
YTD 9.52%
2022 19.00%
2021 -50.17%
2020 -7.81%
2019 295.76%
2018 32.00%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8863 seconds.